Carolina Garrido

Carolina Garrido

Auto-generated profile, based on publicly available information

Carolina Garrido

Duke Human Vaccine Institute

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 June 2021 in Science Immunology
Verified
Journal Article
Open access
PDF file
CGCarolina Garrido
Carolina Garrido
ACAlan D. Curtis
Alan D. Curtis
MDMaria Dennis
Maria Dennis
SPSachi H. Pathak
Sachi H. Pathak
HGHongmei Gao
Hongmei Gao
SPSallie R. Permar
Sallie R. Permar
SARS-CoV-2 vaccines are well tolerated and highly immunogenic in infant rhesus macaques.

8 September 2021 in JCI Insight
Verified
Journal Article
Open access
CGCarolina Garrido
Carolina Garrido
JHJillian H. Hurst
Jillian H. Hurst
CLCynthia G. Lorang
Cynthia G. Lorang
JAJhoanna N. Aquino
Jhoanna N. Aquino
JRJavier Rodriguez
Javier Rodriguez
GFGenevieve G. Fouda
Genevieve G. Fouda
As SARS-CoV-2 continues to spread globally, questions have emerged regarding the strength and durability of immune responses in specific populations. In this study, we evaluated humoral immune responses in 69 children and adolescents with asymptomatic or mild symptomatic SARS-CoV-2 infection. We detected robust IgM, IgG, and IgA antibody responses to a broad array of SARS-CoV-2 antigens at the time of acute infection and 2 and 4 months after acute infection in all participants. Notably, these antibody responses were associated with virus-neutralizing activity that was still detectable 4 months after acute infection in 94% of children. Moreover, antibody responses and neutralizing activity in sera from children and adolescents were comparable or superior to those observed in sera from 24 adults with mild symptomatic infection. Taken together, these findings indicate that children and adolescents with mild or asymptomatic SARS-CoV-2 infection generate robust and durable humoral immune responses that can likely contribute to protection from reinfection.

20 April 2021 in medRxiv
Verified
Preprint
Open access
PDF file
CGCarolina Garrido
Carolina Garrido
JHJillian H. Hurst
Jillian H. Hurst
CLCynthia G. Lorang
Cynthia G. Lorang
JAJhoanna N. Aquino
Jhoanna N. Aquino
JRJavier Rodriguez
Javier Rodriguez
GFGenevieve G. Fouda
Genevieve G. Fouda
As SARS-CoV-2 continues to spread globally, questions have emerged regarding the strength and durability of immune responses in specific populations. In this study, we evaluated humoral immune responses in 69 children and adolescents with asymptomatic or mild symptomatic SARS-CoV-2 infection. We detected robust IgM, IgG, and IgA antibody responses to a broad array of SARS-CoV-2 antigens at the time of acute infection and 2 and 4 months after acute infection in all participants. Notably, these antibody responses were associated with virus neutralizing activity that was still detectable 4 months after acute infection in 94% of children. Moreover, antibody responses and neutralizing activity in sera from children and adolescents were comparable or superior to those observed in sera from 24 adults with mild symptomatic infection. Taken together, these findings indicate children and adolescents with mild or asymptomatic SARS-CoV-2 infection generate robust and durable humoral immune responses that are likely to protect from reinfection.